首页>投融资
SecondWave
未透露
SecondWave Systems是生物超声医学新兴领域的先驱。该公司正在开发一种首创的非侵入性可穿戴超声刺激平台,为患者及其医生提供治疗衰弱或危及生命的疾病的新选择。该公司的SecondWave MINI™设备使用专有的低强度聚焦超声波技术来刺激脾脏,目的是治疗急性和慢性炎症疾病。目前正在对这项技术进行临床研究,以减少COVID-19中的急性炎症,并计划进行其他研究,以研究风湿性关节炎等慢性炎症性疾病的使用情况。
基本信息
-
公司全称SecondWave Systems Inc
-
类型可穿戴超声刺激平台提供商
-
产业领域医疗器械、治疗设备
-
公司人数15~50人
-
地址
-
联系电话
-
邮箱info@secondwaveUS.com
-
成立时间2019-01-01
投融资
-
2024-03-27未透露300万美元ARPA-H
-
2021-04-20未透露400万美元United States Department of Defense
相关投融资企业
C轮
Francis Medical is a dynamic medical device company committed to developing urological cancer treatments that are tough on cancer yet gentle on patients.In September 2020, Coloplast announced that it has completed a USD 4m (DKK 25m) equity investment in Francis Medical
收并购
Gynesonics is a developer of transcervical, uterus-preserving, incision-free technologies for diagnostic and therapeutic applications (avoiding invasive surgical techniques of hysterectomy or myomectomy for symptomatic uterine fibroids). Products include the Sonata system which combines intrauterine ultrasound guidance with targeted radiofrequency ablation.In April 2023, the company closed a financing round of $25M
未公开
BetaGlue Therapeutics是一家临床分期肿瘤公司,该公司开发了一种先进的放疗平台,能够对不可切除的实体瘤和手术切缘进行局部靶向治疗,称为YntraDose。